X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ceftazidime-avibactam (259) 259
index medicus (202) 202
microbiology (165) 165
pharmacology & pharmacy (151) 151
infectious diseases (133) 133
enterobacteriaceae (102) 102
humans (97) 97
in-vitro activity (72) 72
infections (72) 72
klebsiella-pneumoniae (70) 70
gram-negative bacteria (69) 69
pseudomonas-aeruginosa (66) 66
anti-bacterial agents - pharmacology (56) 56
ceftazidime/avibactam (56) 56
anti-bacterial agents - therapeutic use (53) 53
carbapenem-resistant enterobacteriaceae (53) 53
antibiotics (52) 52
double-blind (52) 52
ceftazidime (50) 50
urinary-tract-infections (49) 49
pseudomonas aeruginosa (48) 48
escherichia-coli (47) 47
carbapenemase (41) 41
klebsiella pneumoniae (41) 41
beta-lactamase inhibitor (40) 40
susceptibility (38) 38
avibactam (36) 36
drug resistance (36) 36
microbial sensitivity tests (36) 36
polycyclic compounds (36) 36
resistance (36) 36
bacteria (35) 35
ceftolozane-tazobactam (35) 35
combination (35) 35
biochemical phenomena, metabolism, and nutrition (34) 34
colistin (34) 34
kpc (34) 34
drug resistance in microorganisms (33) 33
immunology (33) 33
mortality (33) 33
antimicrobial resistance (32) 32
bacterial infections and mycoses (32) 32
azabicyclo compounds - pharmacology (30) 30
azabicyclo compounds - therapeutic use (30) 30
pneumonia (30) 30
drug resistance, multiple, bacterial (29) 29
meropenem (29) 29
ceftazidime - therapeutic use (28) 28
complicated intraabdominal infections (28) 28
epidemiology (28) 28
antimicrobial agents (26) 26
plus metronidazole (26) 26
bacteremia (25) 25
ceftazidime-avibactam resistance (25) 25
gram-negative bacteria - drug effects (25) 25
ventilator-associated pneumonia (25) 25
beta lactamases (24) 24
blood-stream infections (24) 24
beta-lactamase (23) 23
critically-ill patients (23) 23
gram-negative bacterial infections - drug therapy (23) 23
male (23) 23
ceftazidime - pharmacology (22) 22
drug combinations (22) 22
drug therapy (22) 22
surveillance (22) 22
us medical-centers (22) 22
internal medicine (21) 21
antibiotic resistance (20) 20
beta-lactamase inhibitors - therapeutic use (20) 20
cre (20) 20
safety (20) 20
β-lactamase (20) 20
adult (19) 19
analysis (19) 19
beta-lactamases (19) 19
efficacy (19) 19
female (19) 19
gram-negative bacterial infections - microbiology (19) 19
health aspects (19) 19
infectious disease (19) 19
klebsiella (19) 19
middle aged (19) 19
tazobactam (19) 19
therapy (19) 19
carbapenems (18) 18
care and treatment (18) 18
ceftolozane/tazobactam (18) 18
clinical trials (18) 18
dosage and administration (18) 18
review (18) 18
urinary tract infections (18) 18
bacterial pneumonia (17) 17
beta-lactamase inhibitors - pharmacology (17) 17
research (17) 17
antimicrobial activity (16) 16
carbapenemases (16) 16
imipenem (16) 16
klebsiella pneumoniae carbapenemase (16) 16
mechanisms of resistance (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


MEDECINE ET MALADIES INFECTIEUSES, ISSN 0399-077X, 09/2019, Volume 49, pp. S6 - S9
Journal Article
ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, ISSN 0939-2661, 07/2018, Volume 53, Issue 7-8, pp. 529 - 542
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2018, Volume 61, Issue 22, pp. 10340 - 10344
Only one FDA-approved β-lactamase inhibitor has ever been orally available: clavulanic acid, approved in 1984. Avibactam, approved by FDA in 2015, is the first... 
CEFTAZIDIME-AVIBACTAM | CHEMISTRY, MEDICINAL | DIAZABICYCLOOCTANES
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 10/2019
Journal Article
Revista Espanola de Cirugia Ortopedica y Traumatologia, ISSN 1888-4415, 11/2018, Volume 62, Issue 6, pp. 471 - 473
There are increasingly more patients with prosthetic implants (orthopaedic prostheses, lumbar instruments, osteosynthesis material). In the last decade,... 
Carbapenemase | Arthrodesis | Ceftazidime/avibactam
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2016, p. AAC.01964-16
Ceftazidime-avibactam (CAZ-AVI) is a recently approved β-lactam β-lactamase inhibitor combination with the potential to treat serious infections caused by... 
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2019, Volume 68, Issue 11, pp. 1823 - 1830
Abstract Background Overcoming β-lactam resistance in pathogens such as Pseudomonas aeruginosa is a major clinical challenge. Rapid molecular diagnostics... 
ceftazidime/avibactam | ceftolozane/tazobactam | Pseudomonas aeruginosa | antimicrobial resistance
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2017, Volume 61, Issue 3
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2018, Volume 62, Issue 8
Carbapenem-resistant and hypervirulent (CR-hvKp) strains have emerged while antimicrobial treatment options remain limited. Herein, we tested the activity of... 
Carbapenem resistance | Susceptibility | Ceftazidime-avibactam | Hypervirulent Klebsiella pneumoniae
Journal Article
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 12/2016, Volume 63, Issue 12, pp. 1619 - 1621
Journal Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 03/2018, Volume 62, Issue 3
Ceftazidime-avibactam (CAZ-AVI) is a promising novel treatment for infections caused by carbapenem-resistant Enterobacteriaceae (CRE). Despite improved... 
carbapenem-resistant Enterobacteriaceae | bacterial genomics | antimicrobial resistance | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | ceftazidime-avibactam | long-read sequencing | Klebsiella pneumoniae | ENTEROBACTERIACEAE
Journal Article
Diagnostic Microbiology and Infectious Disease, ISSN 0732-8893, 05/2019, p. 114835
Journal Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 03/2017, Volume 61, Issue 3
Ceftazidime-avibactam is a novel beta lactam/ beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae (CRE) that produce... 
MORTALITY | VARIANTS | Klebsiella pneumoniae carbapenemase,sequence type 258 | SEQUENCE TYPE 258 | MICROBIOLOGY | ceftazidime-avibactam | resistance | carbapenem-resistant Enterobacteriaceae | EVOLUTION | THERAPY | BETA-LACTAMASE | BACTEREMIA | US HOSPITALS | PHARMACOLOGY & PHARMACY | Klebsiella pneumoniae | ENTEROBACTERIACEAE | KPC
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.